IP Library › Granted Patent US 11,653,874
Granted Patent B2
US 11,653,874 · App. 14/821,672 · Granted May 23, 2023

Method and system for characterizing tissue in three dimensions using multimode optical measurements

Inventors: Daniel L. Farkas (Beverly Hills, CA); Fartash Vasefi (Sherman Oaks, CA); Nicholas MacKinnon (Vancouver, CA)
Assignee: ACCELERITAS CORPORATION
A61B5/443A61B5/14558A61B5/444A61B5/14546A61B5/14551A61B2576/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,653,874
App. No.
14/821,672
Granted
May 23, 2023
Kind
B2
Abstract

A surface of the tissue is illuminated with light having a known wavelength spectrum capable of materially penetrating the tissue. The light remitted from the tissue in response to the illumination is separated into at least two distinguishable polarization components. The intensity of the illumination light remitted from the tissue is measured over a hyperspectral range of wavelengths for the at least two distinguishable polarization components. Based on the preceding measurements and a degree of linear polarization of the remitted light, data representative of the three-dimensional location and one or more characteristics of an abnormal portion of the tissue are produced. Further, the masking effect of melanin may be eliminated to obtain accurate estimations of an anomaly.

Claims (13)

1. A method of characterizing biological tissue, comprising:

illuminating tissue in vivo with a temporal sequence of multiple wavelengths of polarized light comprising a continuum between 400 nm and 1000 nm;

separating light emitted from said tissue in response to said illumination into at least two polarization components, wherein the at least two polarization components comprise different linear polarizations of the separated light, and are captured using parallel and cross orientations of a polarizing filter in a detection path with respect to an orientation of a second polarizing filter in an illumination path used to illuminate the tissue;

calculating a degree of linear polarization of the light emitted from said tissue based on measurements of an intensity for each of the at least two polarization components of the emitted light, respectively;

forming at least two respective hyperspectral image sets from said at least two polarization components;

identifying a distribution of superficial melanin in an illuminated portion of the tissue and cancelling a contribution of the superficial melanin in one or more images in the hyperspectral image sets, and thereafter estimating an amount of oxyhemoglobin, deoxyhemoglobin, or both oxyhemoglobin and deoxyhemoglobin, in the tissue, wherein superficial melanin is melanin between the surface of the skin and 120 μm depth;

generating a three-dimensional model of the tissue comprising an array of individual tissue-characteristic three-dimensional voxels based on the degree of linear polarization of the emitted light as a function of wavelength and position in measurement space; and

determining at least one characteristic of said tissue.

2. The method of claim 1 , wherein the light emitted from the tissue comprises one or more of reflected light, scattered light and fluorescence light, whose intensities form a multimode image dataset.

3. The method of claim 1 , wherein the at least one characteristic of said tissue that is determined is a three-dimensional quantitative spatial distribution of melanin, oxyhemoglobin, deoxyhemoglobin and/or collagen in the illuminated portion of the tissue.

4. The method of claim 3 , further comprising identifying a distribution of deep melanin in the illuminated portion of tissue and cancelling a contribution of the deep melanin in the one or more images in the hyperspectral image sets prior to estimating the amount of oxyhemoglobin, deoxyhemoglobin, or both oxyhemoglobin and deoxyhemoglobin, in the illuminated portion of tissue, wherein the deep melanin corresponds to a melanin having a depth larger than 120 μm from a surface of the tissue.

5. The method of claim 1 , further comprising measuring the intensity for each of the at least two polarization components of the emitted light respectively.

6. The method of claim 1 , wherein the at least one characteristic of the tissue that is determined is a three-dimensional quantitative spatial distribution of melanin, oxyhemoglobin, deoxyhemoglobin and collagen in the illuminated portion of the tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2022
From: SPECTRAL MOLECULAR IMAGING, INC.
To: ACCELERITAS CORPORATION
Reel/Frame 061306/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: FARKAS, DANIEL L.; VASEFI, FARTASH; MACKINNON, NICHOLAS
To: SPECTRAL MOLECULAR IMAGING, INC.
Reel/Frame 047748/0066 →
Continuity (4)
Continuation In Part 14815691 · Jul 31, 2015
Continuation PCTUS2014014330 · Jan 31, 2014
Provisional Application 61759910 · Feb 1, 2013
Related Publication 20150374276A1 · Dec 31, 2015